PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
31.47%
Revenue growth exceeding 1.5x Insurance - Life median of 6.88%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
31.47%
Gross profit growth exceeding 1.5x Insurance - Life median of 6.88%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
29.96%
EBIT growth near Insurance - Life median of 29.96%. Charlie Munger would expect industry-level profitability trends are driving results.
29.96%
Operating income growth near Insurance - Life median of 29.96%. Charlie Munger might chalk it up to standard industry trends.
31.34%
Net income growth exceeding 1.5x Insurance - Life median of 10.51%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
31.32%
EPS growth exceeding 1.5x Insurance - Life median of 6.56%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
31.33%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 6.56%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.53%
Negative OCF growth while Insurance - Life median is -11.53%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-11.53%
Negative FCF growth while Insurance - Life median is -11.53%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
150.41%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 64.29%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
19.92%
5Y revenue/share growth 1.25-1.5x Insurance - Life median of 15.18%. Mohnish Pabrai might attribute the outperformance to scale or brand strength.
6.28%
3Y CAGR of 6.28% while Insurance - Life median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
411.02%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 64.62% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
89.65%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 18.64%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
312.28%
3Y OCF/share growth > 1.5x Insurance - Life median of 18.97%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
406.59%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 130.15% over a decade. Joel Greenblatt might see a standout compounder of earnings.
42.34%
5Y net income/share CAGR > 1.5x Insurance - Life median of 4.65%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
15.44%
3Y net income/share CAGR of 15.44% while Insurance - Life median is zero. Walter Schloss might see a small advantage that can be scaled further.
307.17%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 12.13% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
23.60%
5Y equity/share CAGR > 1.5x Insurance - Life median of 15.52%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
7.49%
3Y equity/share CAGR of 7.49% while Insurance - Life median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.39%
Below 50% of Insurance - Life median. Jim Chanos suspects stagnation or limited capital availability for expansions.
1.45%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
-1.46%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-7.68%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.